Literature DB >> 23437952

Estimating covariate-adjusted log hazard ratios in randomized clinical trials using cox proportional hazards models and nonparametric randomization based analysis of covariance.

Benjamin R Saville1, Gary G Koch.   

Abstract

In the context of randomized clinical trials with time-to-event outcomes, estimates of covariate-adjusted log hazard ratios for comparing two treatments are obtained via nonparametric analysis of covariance by forcing the difference in means for covariables to zero. The method avoids the assumption of proportional hazards for each of the covariates, and it provides an adjusted analysis for the same population average treatment effect that the unadjusted analysis addresses. It is primarily useful in regulatory clinical trials that require analyses to be specified a priori. To illustrate, the method is applied to a study of lung disease with multivariate time-to-event outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23437952     DOI: 10.1080/10543406.2012.755692

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.

Authors:  Yue Zhao; Benjamin R Saville; Haibo Zhou; Gary G Koch
Journal:  J Biopharm Stat       Date:  2015-01-30       Impact factor: 1.051

2.  Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials.

Authors:  Lisa J Woodhouse; Alan A Montgomery; Jonathan Mant; Barry R Davis; Ale Algra; Jean-Louis Mas; Jan A Staessen; Lutgarde Thijs; Andrew Tonkin; Adrienne Kirby; Stuart J Pocock; John Chalmers; Graeme J Hankey; J David Spence; Peter Sandercock; Hans-Christoph Diener; Shinichiro Uchiyama; Nikola Sprigg; Philip M Bath
Journal:  BMC Med Res Methodol       Date:  2021-10-17       Impact factor: 4.615

3.  Discussion on "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes" by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, and Michael Rosenblum.

Authors:  Lisa M LaVange
Journal:  Biometrics       Date:  2021-06-09       Impact factor: 1.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.